ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) - Mikulska, M; Lanini, S; Gudiol, C (Clin Microbiol Infect, 2018)
et al.